<DOC>
	<DOCNO>NCT01015703</DOCNO>
	<brief_summary>The study conduct explore safety tolerability CoVaccine HT healthy male female volunteer . In study volunteer receive intramuscular injection CoVaccine HT .</brief_summary>
	<brief_title>Open-label Safety Tolerability Study CoVaccine HTâ„¢ Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Adult male female non childbearing potential age 25 65 year inclusive 19 35 kg/m2 body mass index ( BMI ) Generally healthy determine pre study medical history , physical examination , 12 lead ECG . Negative hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody human immunodeficiency virus ( HIV ) I II test screen rapid influenza diagnostic test admission . History alcohol abuse last 5 year drug abuse time , current significant alcohol consumption . Fever , active infection ( influenza ) acute gastrointestinal symptom follow prior first dose Subjects previous serious reaction vaccine , angioedema anaphylaxis</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Vaccine , hypertension</keyword>
</DOC>